Q79.6 Ehlers-Danlos syndromes

Name of the Condition

• Ehlers-Danlos syndromes

Summary

Ehlers-Danlos syndromes (EDS) are a group of inherited connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. These conditions result from defects in collagen synthesis or structure, affecting the skin, joints, blood vessels, and other organs. The clinical presentation varies widely across subtypes, with symptoms ranging from mild joint pain to life-threatening vascular complications.

Causes

EDS is caused by genetic mutations affecting collagen or proteins involved in connective tissue integrity. Most subtypes follow an autosomal dominant inheritance pattern, though some are autosomal recessive or X-linked. Mutations in genes such as COL5A1, COL5A2, and TNXB disrupt collagen production or cross-linking, leading to weakened connective tissues.

Risk Factors

• Family history of Ehlers-Danlos syndromes or related connective tissue disorders.
• Inherited genetic mutations associated with specific EDS subtypes.
• Advanced maternal age (in some cases, though genetic factors are primary).

Symptoms

• Joint hypermobility, dislocations, or chronic pain.
• Skin that is easily bruised, stretchy, or prone to scarring.
• Fragile blood vessels or organs, leading to easy tearing or rupture.
• Gastrointestinal issues (e.g., hernias, diverticula).
• Fatigue and chronic pain.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, family history, and genetic testing. Physical exams assess joint mobility, skin elasticity, and tissue fragility. Imaging or laboratory tests may rule out other conditions. Genetic testing confirms specific subtypes by identifying mutations in collagen-related genes.

Treatment Options

Management focuses on symptom relief and preventing complications. Physical therapy strengthens joints and improves stability. Pain management addresses chronic discomfort. Surgical interventions are avoided when possible due to tissue fragility, but may be necessary for severe cases (e.g., organ rupture). Multidisciplinary care (e.g., rheumatology, cardiology) is often required.

Prognosis and Follow-Up

Prognosis varies by subtype, with some forms causing mild symptoms and others leading to life-threatening complications. Regular monitoring for vascular, gastrointestinal, or musculoskeletal issues is essential. Follow-up care includes routine check-ups, imaging, and adjustments to treatment plans based on symptom progression.

Complications

• Vascular rupture or aneurysms (in vascular EDS subtypes).
• Chronic joint dislocations or arthritis.
• Organ herniation or rupture.
• Severe scarring or wound healing issues.
• Cardiovascular abnormalities (e.g., valve defects).

Lifestyle & Prevention

• Avoid high-impact activities that strain joints or tissues.
• Use protective gear to prevent injuries.
• Maintain a balanced diet to support tissue health.
• Engage in low-impact exercise (e.g., swimming) to improve strength.
• Monitor for signs of complications (e.g., sudden pain, bruising).

When to Seek Professional Help

Seek immediate care for:

• Sudden, severe pain (possible organ or vessel rupture).
• Unexplained bruising or bleeding.
• Difficulty breathing or chest pain.
• New or worsening joint instability.
• Signs of infection at wound sites.

Tips for Medical Coders

Document the specific EDS subtype (e.g., classical, vascular) when available, as coding may vary by presentation. Include details on joint involvement, skin findings, or vascular complications to support accurate code assignment. Ensure documentation reflects genetic testing results or clinical criteria for the subtype to justify the diagnosis.